Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$181.44 - $260.22 $462,309 - $663,040
2,548 New
2,548 $640,000
Q3 2021

Nov 15, 2021

SELL
$250.72 - $291.24 $489,405 - $568,500
-1,952 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$235.0 - $310.7 $1.81 Million - $2.39 Million
-7,701 Reduced 79.78%
1,952 $535,000
Q1 2021

May 17, 2021

BUY
$175.6 - $291.43 $1.7 Million - $2.81 Million
9,653 New
9,653 $2.61 Million
Q2 2019

Aug 14, 2019

SELL
$124.65 - $167.39 $2.42 Million - $3.25 Million
-19,396 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$115.84 - $160.31 $43,324 - $59,955
-374 Reduced 1.89%
19,396 $2.85 Million
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $2.24 Million - $3.09 Million
19,770 New
19,770 $2.42 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $10B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.